Low birth weight has been linked to an increased risk of pulmonary hypertension (PH) in premature infants needing oxygen…
Articles by Steve Bryson, PhD
A large proportion of Swedish children younger than 7 who were diagnosed with pulmonary hypertension (PH) started treatment with…
Potential targets to treat pulmonary arterial hypertension (PAH) were identified by analyzing the gene activity of individual lung endothelial…
Seven long noncoding RNA molecules were found to be associated with the development of pulmonary hypertension (PH) in an…
Using a healthcare cost model, researchers in the Netherlands found that an early diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH)…
Rare mutations in the ATP13A3 gene caused a severe inherited form of childhood-onset pulmonary arterial hypertension (PAH), a case…
AER-901, an inhaled formulation of imatinib being developed as a treatment for pulmonary arterial hypertension (PAH), has been granted…
Routine blood screenings and non-invasive clinical tests may predict disease severity and mortality in people with pulmonary hypertension (PH),…
The PAPi blood pressure test was able to accurately predict mortality in Asian people with pulmonary arterial hypertension (PAH),…
The likelihood of developing pulmonary hypertension (PH) is low among people in southern Italy, suggests a study that draws from…
The U.S. Food and Drug Administration (FDA) has accepted an updated application asking that the dry-powder inhalation therapy…
Altavant Sciences has opened ELEVATE 2, its global Phase 2b clinical trial into the safety…